Andrew Sorkin

Partner

Washington, D.C. / New York
andrew.sorkin@lw.com
+1.202.637.3302

PRACTICES

  • Restructuring & Special Situations

BAR QUALIFICATIONS

  • District of Columbia
  • New York

EDUCATION

  • JD, University of Virginia School of Law, 2007
  • BS in Industrial and Labor Relations, Cornell University, 2004

PROFILE

Andrew Sorkin advises companies and other stakeholders on all facets of restructuring matters, in- and out-of-court.

Andrew helps public and private companies, their boards and management, as well as creditors, shareholders, debtor-in-possession lenders, and asset purchasers and investors to navigate a full range of scenarios involving financial distress, including:

  • Prepackaged, prearranged, and traditional chapter 11 proceedings
  • Debtor-in-possession financings
  • Distressed asset sales, including Section 363 sales
  • Cross-border insolvency

As a candid advisor to his clients and effective negotiator with other stakeholders, Andrew excels at building consensus in the most challenging and contentious matters. He draws on his experience advising parties from every vantage point in a restructuring to develop innovative solutions to novel problems.

Andrew also regularly writes and speaks on restructuring topics.

EXPERIENCE

Andrew's representations include advising:

Company-Side Restructurings

  • Vital Pharmaceuticals, the maker of Bang Energy beverage, and certain affiliates in ongoing chapter 11 proceedings in the US Bankruptcy Court for the Southern District of Florida and the sale of substantially all of Vital’s assets to an affiliate of Monster Beverage Corporation
  • Weatherford, one of the largest multinational oilfield services companies, in its US$5.8 billion deleveraging through prearranged restructuring proceedings in the US, Ireland, and Bermuda
  • Hexion, a leading global chemical company, in its more than US$2 billion deleveraging pre-arranged chapter 11 case
  • Alta Mesa Resources, an independent oil and gas exploration and production company with reserves in the Anadarko Basin, in its chapter 11 restructuring
  • Nine Point Energy and affiliates in their chapter 11 proceedings
  • Mallinckrodt Pharmaceuticals, a branded and generic pharmaceutical manufacturer in its pre-arranged chapter 11 cases
  • Verso and New Page, leading North American producers of printing papers, specialty papers, and pulp, in all aspects of their chapter 11 cases*

Creditor, Investor, and Sponsor-Side Restructurings

  • CPF Canada Holdings in their capacity as equity investor in, and DIP lender to, HyLife Windom and affiliates in connection with their pending chapter 11 cases
  • An ad hoc group of creditors in connection with the restructuring of First Energy Solutions and its subsidiary debtors
  • An ad hoc group of first-lien creditors in connection with the chapter 11 restructuring of Appvion and affiliated debtors*
  • A leveraged lease owner participant in the chapter 11 restructuring of GenOn subsidiary NRG REMA*

*Matter handled prior to joining Latham